PON2 and glioblastoma: We further treated GBM cells with 5 and 10 mM VPA for 24 to 72 h, the PON2 mRNA and protein levels reduced by VPA was in a dose-dependent manner using RT-PCR and Western blot (Figure 3C, 3D).